The role of TACI in the molecular pathogenesis of Common Variable immunodeficiency
The role of TACI in the molecular pathogenesis of Common Variable immunodeficiency
批准号:
G0501468/1
负责人:
Hubert Gaspar
金额:
$94.76万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Common variable immunodeficiency (CVID) is a condition which affects the immune system and results in an inability to fight infection, problems with autoimmunity and in some cases development of lymphoma. The gene defect in CVID has only recently been identified. The gene, TACI, is abnormal in CVID but we do not as yet understand why TACI defects leads to the development of the disease. We will first check over 400 CVID patients for abnormalities in TACI so that we can understand how frequent these abnormalities are. Next we plan to look at how abnormal TACI protein works and functions when placed in combination with normal TACI proteins. We also plan to create a mouse model where the TACI gene has been made defective in a way similar to the human condition. This will provide us with a living system where we can examine the effects of TACI defects on the immune system. A greater understanding of these TACI defects will allow us to develop ways of treating CVID in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a lentiviral gene therapy vector for treatment of haemophagocytic lymphohistiocytosis (HLH) due to perforin deficiency
-
批准号:MR/L012855/1
-
项目类别:Research Grant
-
资助金额:$88.04万
-
财政年份:2014
-
负责人:Hubert Gaspar
-
依托单位:
Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency
-
批准号:MR/K015427/1
-
项目类别:Research Grant
-
资助金额:$156.27万
-
财政年份:2013
-
负责人:Hubert Gaspar
-
依托单位:
Development of a lentiviral vector for gene therapy of ADA deficiency
-
批准号:G0802483/1
-
项目类别:Research Grant
-
资助金额:$71.97万
-
财政年份:2010
-
负责人:Hubert Gaspar
-
依托单位:
Development of an enhanced lentiviral vector for gene therapy of ADA-SCID
-
批准号:G0600773/1
-
项目类别:Research Grant
-
资助金额:$40.15万
-
财政年份:2007
-
负责人:Hubert Gaspar
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Penicillium verruculosum中新型TACI抑制剂的发现及其治疗系统性红斑狼疮作用机制研究
-
批准号:JCZRQN202500240
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
MDLC诱导TACI+BAFFR+B细胞活化参与调节实验性自身免疫性脑脊髓炎的机制研究
-
批准号:82171339
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:郭俊
-
依托单位:
从BAFF-TACI信号通路探讨IgA分泌B淋巴细胞归巢在IgA肾病发病中的作用及益气清解方的干预机制
-
批准号:81973675
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:李深
-
依托单位:
系统性红斑狼疮中国人群特异性遗传标记物TACI的验证和功能研究
-
批准号:81801636
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:王勇斐
-
依托单位:
原发性干燥综合征中调节性B细胞功能缺陷及TACI对其调控机制研究
-
批准号:81801604
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:张昊泽
-
依托单位:
BAFF-TACI信号通路介导的B细胞诱导树突状细胞免疫调节功能异常在慢性免疫性血小板减少症中的作用及免疫干预研究
-
批准号:81700110
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:闵亚楠
-
依托单位:
B细胞刺激因子受体BAFF-R、BCMA和TACI介导信号和相互关系在胶原性关节炎发病中作用及受体抑制剂对其的影响
-
批准号:81173075
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:魏伟
-
依托单位:
B淋巴细胞刺激因子与其受体介导实验性关节炎的病理机制及TACI-Ig的治疗作用
-
批准号:30973543
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2009
-
负责人:魏伟
-
依托单位: